POU4F1
POU domain, class 4, transcription factor 1
Also known as: BRN3A, PO4F1_HUMAN, RDC-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01851
- Gene
- POU4F1
- Ensembl
- ENSG00000152192
- Chromosome
- 13
- Canonical length
- 419 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
This gene encodes a member of the POU-IV class of neural transcription factors. This protein is expressed in a subset of retinal ganglion cells and may be involved in the developing sensory nervous system. This protein may also promote the growth of cervical tumors. A translocation of this gene is associated with some adult acute myeloid leukemias. [provided by RefSeq, Mar 2012]
Canonical amino-acid sequenceUniProt
419 residues, UniProt reviewed canonical sequence.
>Q01851|POU4F1
1 MMSMNSKQPH FAMHPTLPEH KYPSLHSSSE AIRRACLPTP PLQSNLFASL DETLLARAEA
61 LAAVDIAVSQ GKSHPFKPDA TYHTMNSVPC TSTSTVPLAH HHHHHHHHQA LEPGDLLDHI
121 SSPSLALMAG AGGAGAAAGG GGAHDGPGGG GGPGGGGGPG GGPGGGGGGG PGGGGGGPGG
181 GLLGGSAHPH PHMHSLGHLS HPAAAAAMNM PSGLPHPGLV AAAAHHGAAA AAAAAAAGQV
241 AAASAAAAVV GAAGLASICD SDTDPRELEA FAERFKQRRI KLGVTQADVG SALANLKIPG
301 VGSLSQSTIC RFESLTLSHN NMIALKPILQ AWLEEAEGAQ REKMNKPELF NGGEKKRKRT
361 SIAAPEKRSL EAYFAVQPRP SSEKIAAIAE KLDLKKNVVR VWFCNQRQKQ KRMKFSATYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POU4F1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 2.4 nTPM
Expression across tissuesHPA
Tissue
- retina: 2.4 nTPM
- testis: 0.9 nTPM
- thymus: 0.7 nTPM
- tonsil: 0.7 nTPM
- lymph node: 0.5 nTPM
- skeletal muscle: 0.4 nTPM
Single-cell type
- myosatellite cells: 10 nCPM
- oocytes: 9.2 nCPM
- mesothelial cells: 4.1 nCPM
- retinal ganglion cells: 3.9 nCPM
- differentiating spermatogonia: 3.3 nCPM
- pdcs: 3.2 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 20 nTPM
- midbrain: 12 nTPM
- spinal cord: 3.9 nTPM
- pons: 2 nTPM
- thalamus: 1.9 nTPM
- white matter: 1.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about POU4F1.
Disease | AllUniProt
Conditions POU4F1 is implicated in, by any mechanism.
- Ataxia, intention tremor, and hypotonia syndrome, childhood-onset (ATITHS) MIM:619352
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 118 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Ataxia, intention tremor, and hypotonia syndrome, childhood-onset
Disease | ImmuneIEDB
Conditions an epitope on POU4F1 was assayed in.
- multiple sclerosis B cell
ReferencesPubMed · IEDB
Publications for POU4F1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Tissue and urokinase plasminogen activators instigate the degeneration of retinal ganglion cells in a mouse model of glaucoma.
2016 · Exp Eye Res · RCR 0.4 · 9 citations - Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
2005 · Arthritis Rheum · RCR 0.1 · 8 citations
Reference: B cellIEDB
1 publication
- High heterogeneity of cross-reactive immunoglobulins in multiple sclerosis presumes combining of B-cell epitopes for diagnostics: a case-control study.
2024 · Front Immunol · RCR 0.9 · 5 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.89
- gnomAD missense Z
- 2.45
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axonogenesis
- cell migration in hindbrain
- cellular response to cytokine stimulus
- cellular response to estradiol stimulus
- central nervous system neuron differentiation
- habenula development
- heart development
- innervation
- intrinsic apoptotic signaling pathway by p53 class mediator
- mesoderm development
- negative regulation of apoptotic process
- negative regulation of gene expression
- negative regulation of neuron apoptotic process
- negative regulation of programmed cell death
- negative regulation of transcription by RNA polymerase II
- neuron apoptotic process
- neuron fate specification
- neuron migration
- neuron projection development
- peripheral nervous system neuron development
- positive regulation of gene expression
- positive regulation of neuron apoptotic process
- positive regulation of osteoclast differentiation
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription regulatory region DNA binding
- regulation of cell cycle
- regulation of DNA-binding transcription factor activity
- regulation of neurogenesis
- regulation of transcription by RNA polymerase II
- sensory system development
- suckling behavior
- synapse assembly
- trigeminal nerve development
- ventricular compact myocardium morphogenesis
- proprioception involved in equilibrioception
Molecular functions
- chromatin binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- GTPase binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- single-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of POU4F1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POU4F1 as an antibody target. Whether an autoantibody or antibody against POU4F1 could matter depends on whether native POU4F1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POU4F1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POU4F1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...